title: Pharmacotherapy of child and adolescent depression.
abstract: Pediatric depression is a prevalent and recurrent condition that persists into adulthood and carries significant impairment, morbidity, and risk of mortality. Although there has been a surge of pediatric antidepressant studies in recent years, depression remains largely understudied, unrecognized, and untreated in children and adolescents. Few antidepressant trials have yielded positive results in pediatric depression. Regulatory agencies recently issued warnings against the use of selective serotonin reuptake inhibitors and newer antidepressants in depressed children and adolescents because of a possible link between their use and the appearance or worsening of suicidal ideation or attempts. The authors review data on efficacy and safety of antidepressants for the treatment of pediatric depression to provide treating clinicians with a basis on which to guide their treatment recommendations.
authors.affiliation: Division of Child Psychiatry, New York State Psychiatric Institute, College of Physicians and Surgeons of Columbia University, 1051 Riverside Drive, Unit 74, New York, NY 10032, USA. mdm2109@columbia.edu
authors.forename: Carmen
authors.initials: C
authors.lastname: Moreno
authors.forename: Ansley M
authors.initials: AM
authors.lastname: Roche
authors.forename: Laurence L
authors.initials: LL
authors.lastname: Greenhill
mesh_terms: D000293:Adolescent; D000928:Antidepressive Agents / Q000627:therapeutic use*; D002648:Child; D015283:Citalopram / Q000627:therapeutic use; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000523:psychology*; D005473:Fluoxetine / Q000627:therapeutic use; D006801:Humans; D017374:Paroxetine / Q000627:therapeutic use; D020280:Sertraline / Q000627:therapeutic use; D012919:Social Behavior
chemical_list: D000928:Antidepressive Agents; D005473:Fluoxetine; D015283:Citalopram; D017374:Paroxetine; D020280:Sertraline